- “New Five-Question Test Helps Assess Asthma Control in Children Under Five Years of Age” (Press release issued by AstraZeneca, PRNewsWire)
- “Cadence painkiller gets priority review, shares up” (Reuters)
- “Merck and Schering-Plough Resolve Previously Disclosed Investigation Under State Consumer Protection Statutes Related to VYTORIN® (ezetimibe/simvastatin) and ZETIA® (ezetimibe)” (Press release issued by Merck & Co., Inc. and Schering-Plough Corporation, BusinessWire)
- “Pfizer Reveals New Phase 1 Data From Two Novel Compounds For Alzheimer’s Disease” (RTT News)
- “Johnson & Johnson Reports 2009 Second-Quarter Results” (Press release issued by Johnson & Johnson, JNJ.com)
- “Study shows memantine improves communication abilities in Alzheimer’s patients” (PharmaBiz.com)
- “Sanofi-aventis Discloses Release Of Expert Statement About Lantus Following Recent Publications In Diabetologia” (RTT News)
- “Nycomed, Japan firm circle Solvay drug unit-source” (Reuters)
- “U.K. Plans Massive Swine-Flu Vaccination” (Wall Street Journal)
- “An Alzheimer’s Drug Mystery” (Forbes)
SUBSCRIBE